ABSTRACT: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), commonly prescribed for type 2 diabetes and obesity, have demonstrated potential anti-inflammatory and immunomodulatory effects that may be beneficial in chronic inflammatory skin conditions such as psoriasis and hidradenitis suppurativa (HS)
Mounjaro, or also Tirzepatide as per its generic name, is a medication approved by the FDA to treat type 2 diabetes
Participants in the semaglutide group achieved a weight loss of at least 5%, 10%, or 15%, and improvements in secondary endpoints, such as waist circumference, blood pressure, and lipid levels, compared to the placebo group
Step 5: Monitor How Your Body Responds Watch for your hunger returning, any changes in blood sugar if you have diabetes, and how your energy and mood shift in the first few weeks